BPC-157 Nasal Spray

BPC-157 is a synthetic pentadecapeptide — fifteen amino acids corresponding to a partial sequence of body protection compound, a protein identified in gastric juice. It is made by solid-phase synthesis rather than extracted from tissue. Its distinguishing physical property is stability: the sequence tolerates aqueous and acidic conditions better than most short peptides, which is why it appears in solution formats where other sequences would not hold up.

This listing ships it dissolved rather than lyophilized: 20 mg of BPC-157 in a sterile isotonic saline base, filled to 30 ml in a sealed bottle with a metered atomizing pump rated at roughly 120 actuations. No reconstitution step is involved. Supplied for laboratory research use only.

BPC-157 has a substantial preclinical literature, concentrated in a small number of research groups and almost entirely in rodent models. Areas of study include:

• Angiogenic signaling — VEGFR2 pathway activation and endothelial tube-formation assays in vitro.
• Fibroblast migration and granulation-tissue readouts in animal models.
• Nitric oxide system interaction — measured alongside NO synthase modulation in rodent work.
• Gut-brain axis signaling, including dopaminergic and serotonergic measurements.
• Aqueous and acid stability, which is what makes the peptide tractable in solution.

Independent replication outside the originating groups remains limited. We make no claim about effects in humans.